Halozyme Therapeutics Stock Sees Relative Strength Rating

In a welcome move, Halozyme Therapeutics (HALO) stock saw its Relative Strength Rating improve from 66 to 71 on Tuesday.   How To Invest In Stocks In Both Bull And Bear Markets This unique rating identifies market leadership by using a 1 (worst) to 99 (best) score that shows how a stock’s price action over the last 52 weeks matched…